Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferric ion (Fe3+) is the trivalent oxidation state of iron and is an essential component of numerous proteins and enzymes required for life. It plays a central role in oxygen transport as part of the heme group in hemoglobin and myoglobin, and it is a critical cofactor for enzymes involved in DNA synthesis and the mitochondrial electron transport chain (Source: PubChem). Under physiological conditions, iron is strictly regulated by proteins such as transferrin and ferritin to prevent the formation of toxic free radicals. However, in pathological states like beta-thalassemia or hereditary hemochromatosis, the body's iron storage capacity is overwhelmed, leading to the accumulation of labile ferric iron (Source: PubMed, PMID: 24551219). This excess Fe3+ promotes oxidative stress via the Fenton reaction, causing progressive damage to the heart, liver, and endocrine organs. Deferiprone is a bidentate chelating agent that specifically targets and binds Fe3+ in a 3:1 ratio, forming a stable complex that is subsequently excreted by the kidneys (Source: FDA Label, Ferriprox). By removing excess ferric iron from both intracellular and extracellular compartments, deferiprone helps mitigate iron-induced organ toxicity and improves clinical outcomes for patients with chronic iron overload.
Chelation of ferric ions (Fe3+) in a 3:1 molar ratio to form a stable, neutral complex that is excreted in the urine.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferric ion (Fe3+) (Fe3+).